Pt. Sawicki et al., EFFECTS OF SMOKING ON BLOOD-PRESSURE AND PROTEINURIA IN PATIENTS WITHDIABETIC NEPHROPATHY, Journal of internal medicine, 239(4), 1996, pp. 345-352
Objectives. To investigate the effects of smoking on blood pressure an
d proteinuria in hypertensive diabetic patients with nephropathy. Desi
gn. Controlled, randomized, cross-over study. Setting. Tertiary care c
entre, University Hospital of Dusseldorf, Germany. Subjects. A total o
f 25 subjects were recruited, each of whom smoked at least 20 cigarett
es a day: 10 normotensive healthy volunteers and 15 hypertensive type
1 (insulin-dependent) diabetic outpatients with diabetic retinopathy a
nd persistent micro- or macroalbuminuria; 10 diabetic patients had nor
mal autonomic function test, whilst five patients showed signs of auto
nomic neuropathy. Interventions. Controlled smoking or nonsmoking over
a period of 8 h on separate days. Main outcome measures. Blood pressu
re was measured every 10 min with an automatic device and urine sample
s were collected every 3 h. Results. Systolic blood pressure increased
during smoking in controls (mean) (11.5 mmHg, P = 0.0001) and in diab
etic patients without autonomic neuropathy (7.9 mmHg; P = 0.018), but
not in patients with autonomic neuropathy (-2.4 mmHg; P = 0.792). Dias
tolic blood pressure increased during smoking in controls (6.2 mmHg; P
= 0.019) but not in diabetic patients (2.5 mmHg; P = 0.204. 0.2 mmHg;
P = 0.956). During smoking, median proteinuria and albuminuria increa
sed in diabetic patients without autonomic neuropathy (8.1 mg mmol(-1)
creatinine, P = 0.002; and 2.6 mg mmol creatinine, P = 0.084). No sig
nificant changes in albuminuria or proteinuria occurred in the other t
wo groups. Conclusions. Smoking increases blood pressure values in hea
lthy subjects and in hypertensive patients with diabetic nephropathy a
nd without autonomic neuropathy. This effect of smoking may be partly
responsible for the faster progression of diabetic nephropathy in smok
ing diabetic patients.